Revolutionizing
Drug Discovery

MolecuLayer is a decentralized blockchain protocol enabling a peer-to-peer marketplace for AI-driven drug discovery and biomolecular research with ESMFold v1.

Vision

MolecuLayer transforms drug discovery and biomolecular research by creating a peer-to-peer marketplace for AI-driven computational tasks like protein folding. Starting with Meta AI's ESMFold v1, it operates as a DAO with model-specific tokens, addressing centralized platform limitations such as commercial use restrictions and high costs. With smart contracts for IP-NFT minting and crowd-funding, MolecuLayer ensures secure ownership and incentivizes complex tasks, powered by the MLYR token for governance, staking, and solver rewards.

Architecture

Solvers

GPU operators process protein folding prompts off-chain using ESMFold v1, storing results on IPFS and earning MLYR rewards.

Researchers

Submit amino acid sequences to the MolecuLayer smart contract, deposit tokens, and receive IP-NFTs for result ownership.

Crowd-Funders

Contribute ERC-20 tokens or ETH to incentivize complex tasks, earning pro-rata IP-NFT shares for resulting data.

Tokenomics

The MLYR token, with a fixed supply of 5 million tokens, powers MolecuLayer's governance, staking, and solver rewards, with 1.5 million emitted over ~7 years.

Key Functions

  • Governance:MLYR holders vote on protocol upgrades and model integrations.
  • Staking:Stakers earn MLYR rewards from GPU Cluster revenue.
  • Solver Rewards:Solvers earn MLYR rewards for completed tasks through GPU Clusters.
  • GPU Cluster Incentives:5% of MLYR incentivizes GPU Cluster operators to deploy MolecuLayer models.

Token Distribution

Solver Rewards20% (1M MLYR)
Team & Advisors20% (1M MLYR)
Investors20% (1M MLYR)
Staking Rewards10% (500K MLYR)
Initial Liquidity10% (500K MLYR)
DAO10% (500K MLYR)
Liquidity Incentives5% (250K MLYR)
GPU Cluster Incentives5% (250K MLYR)

IP-NFTs

MolecuLayer leverages IP-NFTs to secure on-chain ownership of computational results, inspired by Molecule Protocol. Upon task validation, smart contracts mint IP-NFTs embedding result metadata and legal agreements, ensuring transparent and transferable ownership. Crowd-funders receive pro-rata shares, democratizing IP rights for protein folding and biomolecular data.

Roadmap

Q3 2025

Testnet launch with ESMFold v1 DAO, IP-NFT minting, and MLYR rewards.

Q1 2026

Mainnet launch with crowd-funding and staking rewards.

Q3 2026

Add AlphaFold 2/3 derivatives and enhance governance.

Q1 2027

Expand to ligand docking and privacy-focused infrastructure.